MX2016000480A - Composiciones farmaceuticas de pancreatina de alta potencia. - Google Patents

Composiciones farmaceuticas de pancreatina de alta potencia.

Info

Publication number
MX2016000480A
MX2016000480A MX2016000480A MX2016000480A MX2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A MX 2016000480 A MX2016000480 A MX 2016000480A
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
high potency
pancreatin
pancreatin pharmaceutical
compositions
Prior art date
Application number
MX2016000480A
Other languages
English (en)
Spanish (es)
Inventor
Boltri Luigi
Ghidorsi Luigi
Pironti Vincenza
Perrett Stephen
Becker Robert
Arzuffi Paola
Original Assignee
Allergan Pharmaceuticals Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53042009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2016000480(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allergan Pharmaceuticals Int Ltd filed Critical Allergan Pharmaceuticals Int Ltd
Publication of MX2016000480A publication Critical patent/MX2016000480A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/94—Pancreatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX2016000480A 2013-11-05 2014-11-05 Composiciones farmaceuticas de pancreatina de alta potencia. MX2016000480A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361900092P 2013-11-05 2013-11-05
PCT/US2014/063984 WO2015069677A1 (en) 2013-11-05 2014-11-05 High potency pancreatin pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2016000480A true MX2016000480A (es) 2016-10-21

Family

ID=53042009

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016000480A MX2016000480A (es) 2013-11-05 2014-11-05 Composiciones farmaceuticas de pancreatina de alta potencia.

Country Status (13)

Country Link
EP (2) EP3613429A1 (enExample)
JP (1) JP2017500885A (enExample)
KR (1) KR20170052520A (enExample)
CN (1) CN106659773A (enExample)
AU (1) AU2014346930A1 (enExample)
BR (1) BR112016000658A2 (enExample)
CA (1) CA2915671A1 (enExample)
ES (1) ES2834483T3 (enExample)
HK (1) HK1222325A1 (enExample)
IL (3) IL243435B (enExample)
MX (1) MX2016000480A (enExample)
RU (1) RU2015155470A (enExample)
WO (1) WO2015069677A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1319655B1 (it) 2000-11-15 2003-10-23 Eurand Int Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
EP2079445B1 (en) 2007-02-20 2015-11-04 Aptalis Pharma Limited Stable digestive enzyme compositions
WO2009109856A2 (en) 2008-03-07 2009-09-11 Axcan Pharma Inc. Method for detecting infectious parvovirus in pharmaceutical preparations
EP2621476B8 (en) 2010-10-01 2020-12-23 Société des Produits Nestlé S.A. Enteric coated, low-strength pancrelipase formulations
RU2602183C2 (ru) 2011-08-08 2016-11-10 Апталис Фарма Лтд. Способ проведения теста на растворение твердых композиций, содержащих пищеварительные ферменты
US10184121B2 (en) 2013-06-28 2019-01-22 Allergan Pharmaceuticals International Limited Methods for removing viral contaminants from pancreatic extracts
ES2743212T5 (es) 2013-07-22 2023-04-25 Allergan Pharmaceuticals Int Ltd Métodos para preparar pancreatina
WO2015020943A2 (en) 2013-08-09 2015-02-12 Aptalis Pharma Ltd. Digestive enzyme composition suitable for enteral administration

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2751330A (en) * 1952-08-27 1956-06-19 Armour & Co Use of a salt in the extraction slurry in recovering proteolytic enzymes from pancreas gland material
GB928654A (en) 1960-10-25 1963-06-12 Philips Nv Improvements in or relating to the production of pancreatin
US3168448A (en) 1963-01-07 1965-02-02 Wilson & Co Inc Process of preparing a lipolytic enzyme composition
DE2460334C3 (de) * 1974-12-20 1979-09-06 Hoechst Ag, 6000 Frankfurt Verfahren zur Gewinnung von Insulin und Pankreatin aus Schweinepankreas
DE3377506D1 (en) * 1982-12-30 1988-09-01 Nordmark Arzneimittel Gmbh Process for obtaining pancreatin
FR2603804B1 (fr) * 1986-09-17 1989-10-27 Jouveinal Sa Lipases et extraits lipasiques, leur procede de preparation et leur application en therapeutique
DE3927286C2 (de) * 1989-08-18 1997-07-24 Roehm Gmbh Wäßrige Enzym-Flüssigformulierungen
US6051220A (en) 1995-05-31 2000-04-18 Medzyme N.V. And Simon Lodewijk Scharpe Composition to improve digestibility and utilization of nutrients
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
DE19724845A1 (de) * 1996-08-28 1998-03-05 Solvay Pharm Gmbh Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen
US20010046493A1 (en) 2000-02-24 2001-11-29 Alex Margolin Lipase-containing composition and methods of use thereof
AR032392A1 (es) * 2001-01-19 2003-11-05 Solvay Pharm Gmbh Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado.
CA2419572A1 (en) * 2003-02-18 2004-08-18 Axcan Pharma Inc. High dosage protease formulation
US20060198838A1 (en) * 2004-09-28 2006-09-07 Fallon Joan M Combination enzyme for cystic fibrosis
HUE031245T2 (en) 2004-10-14 2017-06-28 Lilly Co Eli Preparations containing lipase, protease and amylase for the treatment of pancreatic insufficiency
MX2008000850A (es) 2005-07-29 2008-03-18 Solvay Pharm Gmbh Procedimientos para la fabricacion de polvo de pancreatina esterilizada.
EP2079445B1 (en) * 2007-02-20 2015-11-04 Aptalis Pharma Limited Stable digestive enzyme compositions
SG184095A1 (en) * 2010-03-19 2012-10-30 Aptalis Pharma Canada Inc Gastro-resistant enzyme pharmaceutical compositions
JP2013525488A (ja) * 2010-05-03 2013-06-20 アプタリス ファーマ リミテッド 消化酵素混合物を含有するパンクレアチンを含むマイクロペレット組成物
EP2621476B8 (en) * 2010-10-01 2020-12-23 Société des Produits Nestlé S.A. Enteric coated, low-strength pancrelipase formulations
CN103060297B (zh) * 2012-12-28 2014-06-25 青岛九龙生物医药有限公司 一种分离纯化胰蛋白酶的方法
CN103060296B (zh) * 2012-12-30 2014-05-21 青岛九龙生物医药有限公司 从动物胰脏中提取胰蛋白酶的方法
ES2743212T5 (es) * 2013-07-22 2023-04-25 Allergan Pharmaceuticals Int Ltd Métodos para preparar pancreatina

Also Published As

Publication number Publication date
BR112016000658A2 (pt) 2018-03-20
JP2017500885A (ja) 2017-01-12
EP3613429A1 (en) 2020-02-26
IL274583B (en) 2022-06-01
CA2915671A1 (en) 2015-05-14
IL274583A (en) 2020-06-30
IL243435B (en) 2020-06-30
IL243435A0 (en) 2016-03-31
EP3003360A4 (en) 2017-04-26
EP3003360A1 (en) 2016-04-13
CN106659773A (zh) 2017-05-10
WO2015069677A1 (en) 2015-05-14
KR20170052520A (ko) 2017-05-12
EP3003360B1 (en) 2020-10-07
ES2834483T3 (es) 2021-06-17
HK1222325A1 (zh) 2017-06-30
RU2015155470A3 (enExample) 2018-09-10
AU2014346930A1 (en) 2016-01-07
RU2015155470A (ru) 2017-08-21
IL284419A (en) 2021-07-29

Similar Documents

Publication Publication Date Title
WO2015019198A3 (en) High potency pancreatin pharmaceutical compositions
MX2016000480A (es) Composiciones farmaceuticas de pancreatina de alta potencia.
MX2015012502A (es) Inhibidores de proteina cinasa dependiente de adn.
SG10201907582WA (en) Bicyclic heterocycles as fgfr4 inhibitors
IN2014DN08867A (enExample)
WO2014153346A8 (en) Engineering a heterogeneous tissue from pluripotent stem cells
MX2016008448A (es) Conjugados de var2csa-farmaco.
IN2015KN00262A (enExample)
MX2015006324A (es) Metodos para la fabricacion de polipeptidos proteoliticamente procesados.
MX2019000536A (es) Nuevas pirimidinas carboxamidas como inhibidores de enzima vanina-1.
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
PH12016500003A1 (en) Compounds and compositions as inhibitors of mek
PH12017501095A1 (en) Piperidine derivatives as hdac1/2 inhibitors
GEP201706621B (en) Benzamides
CA2878796C (en) Derivatives of pyridinone as inhibitors for tissue transglutaminase
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
NZ710291A (en) 2-substituted-6-biarylmethylamino-9-cyclopentyl-9h-purine derivatives, use thereof as medicaments, and pharmaceutical compositions
MX2016006604A (es) Derivados de piperidina con actividad multimodal contra el dolor.
UA116889C2 (uk) Фармацевтична композиція, що містить суміш ізоформ apg101 (cd95-fc)
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2016005545A (es) Analogo de la relaxina humana, composicion farmaceutica del mismo y aplicacion farmaceutica del mismo.
MX2015003034A (es) Jeringa que contiene una composicion, en particular farmaceutica, que comprende inmunoglobulinas, su metodo de fabricacion y uso.